Maglinte, Wenefrida G.

HRN: 00-11-13  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2026
CEFTRIAXONE 1G (VIAL)
05/28/2026
06/03/2026
IV
2g
Od
CAP-MR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines